RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
The benefits are obvious but only time will tell. 2.8% is a high local recurrence rate at 3 years. #breastcancer #IORT #breastcancerresearch https://t.co/sAFf88p2Bz
RT @XoftiCAD: Thank you to Dr. Melvin J. Silverstein, Medical Director of Hoag Breast Program and Gross Family Foundation Endowed Chair in…
Thank you to Dr. Melvin J. Silverstein, Medical Director of Hoag Breast Program and Gross Family Foundation Endowed Chair in Oncoplastic Breast Surgery, & the team at @hoaghealth for their cutting edge research for breast cancer treatment. https://t.co
RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
RT SocSurgOnc RT AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/twIR0qv8Qr McMastersKelly SocSurgOnc https://t.co/uW37lcAHSm
RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
RT @AnnSurgOncol: OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG…
OCTOBER ISSUE: Intraoperative Radiation Therapy (#IORT): A Series of 1000 Tumors. #breastoncology https://t.co/yxzxcMzaPG @McMastersKelly @SocSurgOnc https://t.co/eOdW4pOn9q